Nicotine Patch Prescription for Pack-a-Day Smoker
For an adult smoking one pack (20 cigarettes) per day, prescribe combination nicotine replacement therapy: a 21 mg/24-hour patch applied daily PLUS a short-acting NRT form (gum, lozenge, inhaler, or nasal spray) for breakthrough cravings, continued for a minimum of 12 weeks. 1
Initial Prescription Regimen
Patch Component
- Start with 21 mg/24-hour patch applied daily 1, 2, 3
- Apply one new patch every 24 hours on clean, dry, hairless skin
- Rotate application sites daily
- Can remove at bedtime if vivid dreams occur, then apply new patch in morning 3
Short-Acting NRT Component
Choose ONE of the following based on patient preference:
Nicotine Gum:
- 4 mg strength (since smoking ≥20 cigarettes/day indicates high dependence) 4, 2
- Use one piece when cravings occur
- Maximum 24 pieces per day
- Avoid food/beverages 15 minutes before and after use 2
Nicotine Lozenge:
- 4 mg strength if first cigarette within 30 minutes of waking; 2 mg if after 30 minutes 2
- Maximum 20 lozenges per day
- Avoid food/beverages 15 minutes before and after use
Other options: Nasal spray (1-2 doses/hour, max 40 doses/day) or oral inhaler (puff for 20 min/cartridge every 1-2 hours, max 16 cartridges/day) 2
Duration and Tapering Schedule
Standard 12-Week Protocol 1
Weeks 1-6:
- 21 mg patch daily + short-acting NRT as needed for cravings
Weeks 7-8:
- Step down to 14 mg patch daily + short-acting NRT as needed
Weeks 9-10:
- Step down to 7 mg patch daily + short-acting NRT as needed
Weeks 11-12:
- Continue 7 mg patch daily, begin tapering short-acting NRT use
Extended Therapy Option
- May extend treatment to 6-12 months to promote continued cessation, particularly if patient has difficulty maintaining abstinence 1
- Therapy can be extended while attempting to avoid longer periods if possible
Dose Adjustment Considerations
If 21 mg patch insufficient for craving control:
- Consider increasing to 35 mg or 42 mg patch (use two 21 mg patches simultaneously or one 21 mg + one 14 mg patch) 1
- This higher dosing is safe; blood nicotine levels from NRT remain significantly lower than from smoking 1
- Monitor for increased nausea or skin irritation 5, 6
Important caveat: While higher doses (42-44 mg) have been studied and appear safe 5, moderate-certainty evidence suggests 21 mg patches may be as effective as higher doses for most smokers 7. Reserve dose escalation for patients with persistent severe cravings despite combination therapy.
Critical Implementation Points
Timing
- Ideally start patch 1-2 weeks BEFORE quit day (preloading) - moderate-certainty evidence suggests this improves quit rates (RR 1.25) 7
- Continue through quit day and beyond as scheduled
Follow-Up Schedule
- First follow-up within 2 weeks of starting pharmacotherapy (can extend to 3 weeks if needed) 1
- Additional follow-up at minimum 12-week intervals during therapy
- Continue follow-up after completion of therapy
Behavioral Support
- Combination NRT works best with behavioral counseling 1, 8
- Provide skills training, social support, and motivational interviewing
- Telephone counseling (minimum 3 calls) is effective if in-person unavailable 8
Safety Considerations
NRT is well-tolerated:
- Nicotine toxicity is rare and transient, even with combination therapy 1
- Blood nicotine levels from combination NRT remain significantly lower than from continued smoking 1
- Safe in cardiovascular disease - no significant adverse effects demonstrated 4
Common side effects:
- Patch: Local skin irritation (can rotate sites; remove if severe dermatitis develops) 3
- Gum/lozenge: Hiccups, dyspepsia 2
- Overall serious adverse event rates are low (approximately 3%) with no clear increase versus placebo 9
Use caution (but not contraindicated) in:
- Recent MI (≤2 weeks), serious arrhythmia, or unstable angina 2
- Pregnancy (NRT safer than continued smoking) 4, 10
Why Combination Therapy?
High-certainty evidence demonstrates combination NRT (patch + short-acting form) is more effective than single-form NRT (RR 1.25,95% CI 1.15-1.36), resulting in approximately 8 additional quitters per 100 treated 9, 7. The patch provides steady baseline nicotine levels while short-acting forms address breakthrough cravings, mimicking the dual pharmacokinetic profile smokers are accustomed to.
Common Pitfalls to Avoid
- Underdosing: Don't start with 14 mg patch for pack-a-day smokers - they need 21 mg 4, 2
- Monotherapy: Don't prescribe patch alone - combination therapy significantly more effective 1, 9
- Inadequate duration: Don't stop at 8 weeks - minimum 12 weeks recommended, consider extending to 6-12 months 1
- Cutting patches: Never cut patches into smaller pieces 3
- Premature discontinuation: Encourage continued therapy through brief slips; withdrawal symptoms peak at 1-2 weeks then subside 1